Medical Weight Loss

Losing weight is a challenge for most people, especially as we age. Along with a healthy diet and physical exercise, medications like semaglutide and tirzepatide may help in weight reduction.

Semaglutide

FAQs

How is it administered?

Semaglutide or tirzepatide is a once weekly injection administered by you or your healthcare provider. Your dose is based on your progress and response to the medication.

Are there any side effects?

Common side effects include nausea, vomiting, stomach bloating, constipation, acid reflux. Side effects usually resolve within a few weeks. Very rare side effects include pancreatitis, gall stones, and intestinal blockage.

Am I a candidate for semaglutide or tirzepatide injections?

Semaglutide or tirzepatide is not known to interact with any medications. If you have a history of thyroid cancer or if you have endocrine growths or tumors, you are not a candidate. If you are pregnant or nursing, you are not a candidate.

When can I expect to see weight loss?

Usually, it takes 2 weeks to 1 month to start seeing weight loss.

Will I have to be on semaglutide or tirzepatide for the rest of my life?

You can be on semaglutide or tirzepatide for as long as you desire, however, once you have achieved your goal weight, your health care provider will discuss maintenance options.

Is semaglutide or tirzepatide addictive?

Semaglutide and tirzepatide are not addictive and there is no danger in suddenly stopping the medications.

How much does it cost?

There is a monthly fee which covers your visits and medication. Your health care provider will discuss pricing with you.

Semaglutide, a GLP-1 (glucagon-like peptide-1) agonist, is a physiologic hormone that suppresses appetite and slows down digestion. GLP-1 agonists have been widely used for years to treat  those with Type 2 diabetes. More recently, GLP-1 agonists were FDA approved for weight loss in obese and overweight individuals. Administered subcutaneously once weekly, semaglutide may help people lose 10-20% of their current body weight.

Tirzepatide

Tirzepatide contains a GLP-1 (glucagon-like peptide-1) agonist and a GIP (glucose-dependent insulinotropic polypeptide) agonist, which are both physiologic hormones that aid in suppressing appetite and slowing down digestion. This dual-agonist medication is the first of it’s kind, recently FDA approved for weight loss in obese and overweight individuals.